19 June 2013
Keywords: Clinical trials, Off-label marketing, Antipsychotics, USA
Article | 05 December 2011
US federal rules and regulations related to transparency of prescription drug studies and prohibitions on off-label marketing are the focus ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.
5 December 2011
18 June 2013
© 2013 thepharmaletter.com